Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
NCT ID: NCT04422691
Last Updated: 2021-06-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
5 participants
OBSERVATIONAL
2020-07-01
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound
NCT01081210
Sonography in an Unselected Population of Acute Admitted Patients With Respiratory Symptoms
NCT01486394
The Role of Ultrasound in COVID-19
NCT04377035
The Value of Ultralow Dosis CT and Ultrasound in the Diagnosing of Pneumonia in the Emergency Department
NCT04645030
Influence of Routinely Adding Ultrasound Screening in Medical Department
NCT01331187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Covid-19 suspected
Emergency department patients with suspected or diagnosed COVID-19 disease. All patients will be screened at triage and put into isolation if suspected disease. Ultrasound of the patients lungs will be performed after patient consent and findings will be recorded and categorized (Soldati et al., 2020). The use of ultrasound and registration of data will not affect the regular patient evaluation, treatment or logistics.
Lung ultrasound
After verbal consent the enrolled patients' lungs are evaluated with ultrasound while in isolation. The lungs are divided into 3 fields and findings are categorized according to Soldati et al., 2020.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lung ultrasound
After verbal consent the enrolled patients' lungs are evaluated with ultrasound while in isolation. The lungs are divided into 3 fields and findings are categorized according to Soldati et al., 2020.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* recent negative COVID-19 test
* no indication for isolation in the Emergency Department
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Haukeland University Hospital
OTHER
Ullevaal University Hospital
OTHER
Nordlandssykehuset HF
OTHER
Sorlandet Hospital HF
OTHER_GOV
Drammen sykehus
OTHER
Sykehuset Telemark
OTHER_GOV
Helse Stavanger HF
OTHER_GOV
University Hospital, Akershus
OTHER
St. Olavs Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Petter Bjørnsen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
NTNU/St. Olav's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haukeland universitetssykehus
Bergen, , Norway
Nordland Hospital
Bodø, , Norway
Drammen sykehus
Drammen, , Norway
Sørlandet sykehus, Kristiansand
Kristiansand, , Norway
Akershus University Hospital
Oslo, , Norway
Ullevål University Hospital
Oslo, , Norway
Sykehuset Telemark HF
Skien, , Norway
Stavanger Universitetssjukehus
Stavanger, , Norway
St Olavs Hospital
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK129805
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.